Skip to main content
  • Clinical Trials
  • SPRinstitute™ Library
Menu
Home
SPR
  • Healthcare Professionals
    • SPRINT® PNS System
      • Overview
      • Product Details
    • Clinical Evidence
    • Video Resources
    • Reimbursement
    • Education
    • Safety Information
    • MRI Safety Information
  • Patients & Caregivers
    • SPRINT® PNS System
      • Why SPRINT?
      • How It Works
      • What To Expect
      • Helpful FAQs
      • Safety Information
      • MRI Safety Information
    • Resources
      • Overview
      • Instructional Videos
      • Patient Stories
      • Recursos para pacientes
      • Clinical Evidence
  • About Us
    • About SPR
    • Leadership
    • Company Credo
  • News
  • Events
  • Careers
    • Overview
    • Job Listing
  • Contact Us

SPR is now part of Medtronic.

More Info

News & Press Releases

aetna policy promotion press release aetna policy promotion press release

Company news

SPR announces expanded coverage for SPRINT® PNS System nationwide

Read Now

Press releases

View All
ASPN July 2025 Release Thumbnail v1 ASPN July 2025 Release Thumbnail v1

ASPN 2026 to feature three abstracts on SPRINT® PNS

Press releases + media
real world evidence low back real world evidence low back

SPRINT® PNS publication highlights sustained benefits in low back pain patients

Press releases + media Research, data + publications
2026 SPR Top Workplaces Award 2026 SPR Top Workplaces Award

SPR ranks in top ten while winning 5th consecutive Top Workplaces Award

Company news Press releases + media

News

View All
real world evidence low back real world evidence low back

SPRINT® PNS publication highlights sustained benefits in low back pain patients

Press releases + media Research, data + publications
2026 SPR Top Workplaces Award 2026 SPR Top Workplaces Award

SPR ranks in top ten while winning 5th consecutive Top Workplaces Award

Company news Press releases + media
RESET low back PR image RESET low back PR image

Data published in Interventional Pain Medicine indicates participants who received SPRINT PNS as prescribed were three times more likely to achieve meaningful pain relief.

Press releases + media Research, data + publications
Top-Workplace-2026 Top-Workplace-2026

SPR featured as a Top Workplace by USA Today for the second consecutive year

Company news
Case alumnus Maria Bennett Case alumnus Maria Bennett

Alumna Maria Bennett featured for leadership in advancing pain management innovation

Company news
aetna policy promotion press release aetna policy promotion press release

SPRINT® PNS System now covered nationally by Aetna®

Company news Press releases + media
  • Healthcare Professionals
    • SPRINT® PNS System
      • Overview
      • Product Details
    • Clinical Evidence
    • Video Resources
    • Reimbursement
    • Education
    • Safety Information
    • MRI Safety Information
  • Patients & Caregivers
    • SPRINT® PNS System
      • Why SPRINT?
      • How It Works
      • What To Expect
      • Helpful FAQs
      • Safety Information
      • MRI Safety Information
    • Resources
      • Overview
      • Instructional Videos
      • Patient Stories
      • Recursos para pacientes
      • Clinical Evidence
  • About Us
    • About SPR
    • Leadership
    • Company Credo
  • News
  • Events
  • Careers
    • Overview
    • Job Listing
  • Contact Us
  • Compliance
  • Consumer Health Data Request Form
  • CPRA Requests
  • FCOI Policy
  • Indications for Use
  • MRI Safety Information
  • Patent Information
  • Product Terms and Conditions
  • Safety Information
  • Trademarks
  • Billing Portal
Home
  • Consumer Health Data and Information Privacy Policy
  • Terms of Use
Visit us on Facebook
Visit us on Twitter
Visit us on Instagram
Visit us on YouTube
Visit us on LinkedIn

The SPRINT Peripheral Nerve Stimulation (PNS) System is indicated for pain management in adults who have severe intractable chronic pain of peripheral nerve origin, as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach. It is intended to be implanted for up to 60 days and provide sustained pain relief for up to 3 months after the end of treatment. The SPRINT PNS System is not intended to be placed in the region innervated by the cranial and facial nerves. Refer to Indications for Use for the SPRINT System’s additional indication referencing acute pain. 

Physicians should use their best judgment when deciding when to use the SPRINT PNS System. For more information see the SPRINT PNS System IFU. Most common adverse events are skin irritation and erythema. Results may vary. Rx only.

View references for support of all claims.

Product and brand names/logos are registered or common law trademarks of SPR.

© 2026 SPR. All Rights Reserved.